Enas Roumieh, Waqas Bin Ismail, Samahir Sheikh Idris
Hepatobiliary malignancies, such as gallbladder carcinoma (GBC), cholangiocarcinoma (CCA), and hepatocellular carcinoma (HCC), continue to be extremely deadly because of their late diagnosis, intertumoral heterogeneity, recurrence, and resistance to treatment. Finding new molecular drivers is crucial to enhancing diagnosis and therapy. Hepatobiliary tumor biology is significantly regulated by the ...
REVIEW | Published: 31 Oct 2025
Asia-Pacific Journal of Oncology, Articles, Volume 6 (2025)
Pages: 55-69 PDF(3633KB) Views:216Downloads:6